GlaxoSmithKline Merger Completion Delayed To Year-End
The planned merger of SmithKline Beecham and Glaxo Wellcome will be delayed, likely until the end of the year, due to continued Federal Trade Commission inquiries.
The planned merger of SmithKline Beecham and Glaxo Wellcome will be delayed, likely until the end of the year, due to continued Federal Trade Commission inquiries.